ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

PSH Assessment Measure

PSH Assessment Measure
Clinical Feature Scale (CFS)
  0 1 2 3 Score
Heart rate (BPM) <100 100 to 119 120 to 139 ≥140  
Respiratory rate (breaths/minute) <18 18 to 23 24 to 29 ≥30  
Systolic blood pressure (mmHg) <140 140 to 159 160 to 179 ≥180  
Temperature (°C) <37 37 to 37.9 38 to 38.9 ≥39  
Sweating Nil
(none)
Mild
(moist skin)
Moderate
(beads of sweat)
Severe
(profuse generalized sweating)
 
Posturing during episodes Nil
(none)
Mild
(increased tone but not requiring treatment)
Moderate
(increased tone requiring treatment)
Severe
(very increased tone refractory to treatment)
 
CFS subtotal =  
Diagnosis Likelihood Tool (DLT)
Score as "1" if present Score
Clinical features occur simultaneously  
Episodes are paroxysmal in nature  
Over-reactivity to normally nonpainful stimuli  
Features persist ≥3 consecutive days  
Features persist ≥2 weeks post-brain injury  
Features persist despite treatment of differential diagnoses  
Medication administered to decrease sympathetic features  
≥2 episodes daily  
Absence of parasympathetic features during episodes  
Absence of other presumed cause of features  
Antecedent acquired brain injury  
DLT subtotal =  
Combined total (CFS + DLT) =  
Use CFS + DLT for diagnosis:
  • <8 = PSH unlikely
  • 8 to 16 = PSH possible
  • ≥17 = PSH probable
If total score 8 or greater, then use the CFS scale for monitoring of evolution (document daily maximal score).
PSH: paroxysmal sympathetic hyperactivity; BPM: beats per minute.
Adapted with permission from: Baguley IJ, Perkes IE, Fernandez-Ortega JF, et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: Consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma 2014; 31:1515. Copyright © 2014 Mary Ann Liebert, Inc. All rights reserved.
Graphic 122271 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟